¤j¨§¤¤§ÜÀç¾i¦]¤l¤§±´°Q¤Î¨ä¹ï¹}¾i®ÄªG¤§¼vÅT

¡@

¤@¡B«e ¨¥

»·¦Û¦è¤¸«e1000¦~¡A¤j¨§(soybean)¤w¬°»·ªF¦a°Ï¡A¯S§O¬O¤¤°ê¤Î¤é¥»¤§­¹ª«²Õ¦¨¡F¦ý¦b¦è¤è°ê®a¤j¶q®â´ÓªÌ¡A¤D¬O¤Q¤E¥@¬ö¥½´Á¡A§@¬°²i½Õ¥Îªo(cooking oil)¨Ó·½¡C1917¦~¡AOsborne and Mendel¸ÕÅç¬ã¨s«á¶}©l¡A¦h¦~¨Ó¸g¥[¼ö³B²z¤§¤j¨§²Ë(heattreated soybean meal)¤w¼sªx¥Î¬°°Êª«¤§³J¥Õ½è¨Ó·½¡C

¥H¥Í¤j¨§©Î¥[¼ö¤£·í¤§¤j¨§²ËÁý¹}¥J¯b¡A·|­°§C¹}®Æ±Ä­¹¶q¡B­°§C¹ï¤é³¤¤´á¡BºÒ¤ô¤Æ¦Xª«¡B¯×½è¤§®ø¤Æ»P§l¦¬¡F¨Ã­°§C¤w§l¦¬¤§´áªº»W¿n¡A´£°ªÅé¯×ªÕ¤§¤À¸Ñ§@¥Î¡A²×¦Ó­­¨î¹}®Æ§Q¥Î®Ä²v¡C¦Ó¹ï¹«¡BÂúÃZ¤ÎÂû°¦¦Ó¨¥¡A¥ç¨ã¯ØŦ¸~¤j¡B¯ØŦ»Ã¯À¤Àªc¼W¥[¤§¤£¨}¼vÅT¡C

¤wª¾¤j¨§§Ü­ì¤§§í¨î¥Íªø¡B¤zÂZ¸z¹D¤Î²Õ´¥NÁ¡A«Y¦]§ÜÀç¾i¦]¤l(anti-nutritional factors)¤§¦s¦b©Ò­P¡F¥]¬Atrypsin inhibitors¡Blectin¡Bglycinin¤Îconglycininµ¥¡C

Pontit et al. (1987)§Q¥ÎªÎ¨|½Þ°¦¤ñ¸û¤j¨§²Ë»P¥Í¤j¨§¤§¹}¾i®ÄªGµo²{¡AÀHµÛ¥Í¤j¨§¥Î¶q¤§¼W¥[¡A½T¦³­°§C¥Íªø¡A¹}®Æ®Ä²v»P±OÅé«~½è¤§¼vÅT¡F¦ÓCook et al. (1988)¥H§C¶qKunitz trypsin inhibitorÁý¤©¥Íªø½Þ¤ÎªÎ¨|½Þ¡A¦A¦¸ÃÒ¹ê¥Í¤j¨§¤¤©Ò§t¤§§í¨î¦]¤l½T¦³§í¨î¥Íªøªº®ÄªG¡C

¤G¡B¤j¨§¤¤§ÜÀç¾i¦]¤lªº±´°Q

¥J¯bÁý¤©§t¤j¨§©Î¥[¼ö¤£·í¤§¤j¨§²Ë¤é³¡A¨ä¥Íªø©Ê¯à»·¸û§t¦×¯»©Î¨Å³J¥ÕªÌ¬°®t(Grant¡A1989)¡Cªí¤@¬°¹«Áý¤©§t¦UºØ³J¥Õ½è¨Ó·½©ÎµL³J¥Õ½è¤é³¤§¥Íªø±¡§Î¤ñ¸û¡C²b³J¥Õ½è§Q¥Î(NPU¡Anet protein Utilization)¡A¹}®Æ±Ä­¹¶q¤Î¼W­«¥H¥Õ³J¥Õ(egg albumin)¬°³Ì¨Î¡A¨ä¦¸¬°¸g¥[¼ö³B²z¤§¤j¨§²Ë¡A¾lªÌ¨Ì§Ç¬°¥Í¤j¨§¸É¥Rª«¡B¥Í¤j¨§¡FµL³J¥Õ½è¤é³²Õ³Ì®t¡A©ó10¤é¸ÕÅç´Á¶¡Áö¦³±Ä­¹(191§J)¡A¦ý¤wµL²b³J¥Õ§Q¥Î¡A¥BÅé­««ùÄò¥¢­«¤¤(ªí¤@)¡C§@ªÌ«ü¥X¡A¥Í¤j¨§»P¥[¼ö³B²z¹L¤§¤j¨§²Ë¶¡¹ï¥Íªø©Ê¯à¦³¦p¦¹¤j¤§®t²§¡A¥D¦]©ó¤j¨§¤¤©Ò§t½Ñ¦h§ÜÀç¾i¦]¤l(anti-nutritional factors)¤§¬G¡F¨Ò¦ptrypsin inhibitors¤Îlectin (Liener, 1981)¡C³\¦h³ø§i«ü¥X¡A§ÜÀç¾i¦]¤l¤§¦s¦b¡A·|­°§C¹}®Æ±Ä­¹¶q(Liener, 1981)¡A­°§C¤é³¤¤´á(Nitsan and Liener, 1976)¡BºÒ¤ô¤Æ¦Xª«(Santidrian et al., 1973)¡B¯×½è(Sklan et al., 1973)¤§®ø¤Æ»P§l¦¬¡F­°§C¤w§l¦¬¤§´áªº»W¿n(Grant et al., 1986)¡B´£°ªÅé¯×¤§¤À¸Ñ§@¥Î(Grant et al., 1988)¡A¦]¦Ó­­¨î¹}®Æ§Q¥Î®Ä²v¡A­°§C¥Íªø©Ê¯à¡C¥Í¤j¨§¥ç·|»¤µo¯ØŦ»Ã¯À(Lyman and Lepovsky, 1957¡FGertler and Nitsan, 1970)¤ÎÁx¥Ä(Sklan et al., 1973¡FRoy and Schneeman, 1981)¹L«×¤Àªc¡A¨Ï¦¹¨Ç§@¥Î¤é³Àç¾i¤À¤§¦¨¥÷³à¥¢¡A¤Þ°_®ø¤Æ¡B§l¦¬¤£¨}¡CCoates et al. (1970)«ü¥X¡A¥Í¤j¨§¤¤©Ò§t¤§¥Íªø§í¨î¦]¤l·|³y¦¨¸z¤ºµß¬Û¤§ÅܤơF¥¿½T¾÷¨îÁö¥¼©ú½T¡A¦ý¥i¯à»P¥Í¤j¨§¤§Áý¤©¡A·|ªýê¬Y¨Ç­G¸z¹D¤¤²Óµß¤§¼W´Þ¡A¦]¦Ó§ïÅܸz¹D²Óµß¶¡¤§¥­¿Å¡A¨Ã¥B³y¦¨§ó¦h¯f­ì©Ê«~¨t¤§²Óµß©ó¸z¤¤¼W´Þ¦³Ãö(Lhuillery et al., 1982)¡C

ªí¤@ ¤j ¨§ ¹ï ¥® ¯b ¸V ¤§ ¥Í ªø §í ¨î §@ ¥Î

¡@

¥Í ¤j ¨§

¸g ¥[ ¼ö ³B ²z

¤§ ¤j ¨§ ²Ë

¹«¤Î¤j¥Õ¹«

¥Ð¹«¤Î¤ÑªÇ¹«

Âû°¦¤ÎÂúÃZ

ó㽤Î

Ã}¤û

½Þ

¯Ì¦Ï

µU

¤HÃþ

¡Ï¡Ï

¡Ï¡Ï

¡Ï¡Ï

¡Ï¡Ï

¡Ï¡Ï

¡Ï¡Ï

¡Ï¡Ï

¡H

¡H

¡Ð

¡Ð

¡Ð

¡Ð

¡Ï

¡Ï

¡Ï

¡Ð

¡Ð

¡Ï¡Ï¡A±j¯P§í¨î¥Íªø¡F¡Ï¡A³y¦¨ÅãµÛ©Ê¥Íªø§í¨î§@¥Î¡F

¡Ð¡A¹ï¥Íªø©Ê¯àµL·l®`¡F¡H¡A¤£½T©w¡C

¥Í¤j¨§¹ï¦hºØ¥®¯b¤§¥Íªø§í¨î§@¥Î·¥¬°±j¯P(ªí¤@)¡A¥]¬A¹«¡B¤j¥Õ¹«¡B¥Ð¹«¡B¤ÑªÇ¹«¡BÂû°¦¡BÂúÃZ¡Bóγ½¡BÃU³½¡BÃ}¤û¡B½Þ°¦»P¥J¦Ïµ¥¡A¦Ó¹ïµU¤l»P¥®¨àªº¼vÅT«h¥¼½Tª¾¡C¸g¥[¼ö³B²z¹L¤§¤j¨§²Ë¤´¹ïÃ}¤û¡B½Þ°¦»P¥J¦Ï¨ã¦³ÅãµÛ¤§¥Íªø§í¨î§@¥Î¡AÅã¥Ü¥[¼ö³B²z¤§¤j¨§²Ë¤´¦³§ÜÀç¾i¦]¤l¤§¦s¦b¡CBarrat et al.(1978)¡AKilshaw and Si-ssons(1970)«ü¥X¡A¥Í¤j¨§¹ïÃ}¤û¤§¥Íªø§í¨î§@¥Î¡A¤D¦]Áý¹}¥Í¤j¨§«á¤ÞµoIgE¡AIgGµ¥§ÜÅéµo¥Í¤j¨§©Ò§tªº¦¨¥÷¡Ðglycinin¡Bconglycinin²£¥Í¹L±Ó©Ê¤ÏÀ³¡F³y¦¨¤p¸z¤W¥Ö²Ó­M±Y¸Ñ¡B¤W¥Ö²Ó­M§e²{¤£³W«h¤Æ¡A¸zµ³¤òÅܲʡBÅܵu¡A§õ°ö©ø¤ó¸¢ºÛ(Lieberkuhn crypts)¥[²`µ¥¸z¹D¶Ë®`¡F­P¨Ï®ø¤Æ²G³z¹L¤p¸zµo¥ÍÅܤơAÀç¾i¤À¤§²b§l¦¬¦]¦Ó­°§C¡C¥Í¤j¨§©Î¸g¥[¼ö³B²z¹L¤§¤j¨§²ËÁý¤©¥J½Þ³y¦¨¤§¬Û¦P¼vÅT¡A¥iÂǥѨŻs«~¤§¨ú¥N¦Ó®ø¥¢¡FGrant(1989)«ü¥X¡A¤j¨§²Ë¤¤©Ò§t¤§¤j¨§§Ü­ì(soybean antigens»¤µo¥J½Þ¤§ce-ll-mediated delayed hypersensitivity reactions¡A¦Ó¨Ï¥Íªø©Ê¯à­°§C¡CMiller et al.(1984a¡Bb)¤]«ü¥X¡AÂ÷¨Å«á¤§¹L±Ó©Ê¤ÏÀ³(post-weaning hypersensitivity reactions)»P¥Íªø°±º¢¡A¥i©ó¥J½ÞÂ÷¨Å«e±µ¨ü¤Ö¶q¸g¥[¼ö³B²z¹L¤§¤j¨§²Ë¡A¨Ï§K¬Ì¨t²Î¼W¥[­@¨ü©Ê¡A´î¤ÖÂ÷¨Åªº¸gÀÙ·l¥¢¦ÓÀò±o§ïµ½¡C

¤é³¤¤§t¦³¥Í¤j¨§¡A¥ç¹ï¥J¯b¤§¯ØŦ¤j¤p¤Î¯ØŦ»Ã¯À¤Àªc¦³¼vÅT¡C·íÄá­¹¥Í¤j¨§¤é³«á¡A·|³y¦¨¹«¡B¤j¥Õ¹«¡B¥Ð¹«¡B¤ÑªÇ¹«¡BÂû°¦¤ÎÂúÃZ¤§¯ØŦ¸~¤j»P¯ØŦ»Ã¯À¤Àªc¼W¥[(ªí¤G¡AGrant, 1989)¡FRoy and Schnecman (1981)¡BRackis et al. (1979)«ü¥X¡A¥Í¤j¨§¤é³¼W¥[¯ØŦ¤¤trypsin¡Bchymotrypsin¡Bamylase¤Îesterase¤§¤Àªc¡A¦]¦Ó­°§C¯ØŦ¤¤trypsin¡Bohymotrypsin¤§¤ô·Ç¡A¾É­P¯ØŦ¤¤»Ã¯À¦X¦¨³t²v¼W¥[¡F­Y«ùÄòÁý¹}¡A«h·|¦]²Ó­M¤§¼W¤j»P¼W¥Í³y¦¨¯ØŦ¸~¤j¡C¹ï¥J½Þ¦Ó¨¥¡A¥Í¤j¨§¤é³·|§ïÅܯØŦ¥\¯à¡A¦ý¹ï¤j¤p«hµL¼vÅT¡A±©¨ã¦³¤U­zÅܤơG·í­º¦¸±µ¨ü¥Í¤j¨§¤é³®É¡A¯Ø²G»P¯Ø³J¥ÕúA¤§¤Àªc¼W¥[¡F«ùÄòÁý¹}¤U¡A·|ºû«ù¼Æ¤Ñªº¤W¤É²{¶H¡AÀH«á«hµo¥Í¯ØŦ»Ã¯À¤Àªc¤£¨¬¡A¯ØŦ¤¤trypsin¡Bchymotrypsin¶q¤j¤j¦a­°§C(Yen et al., 1977)¡C¦]¦¹¡A¥H¥Í¤j¨§Áý¤©¥J½Þ¡AÄY­«¯}Ãa¯ØŦ»Ã¯À¤§¦X¦¨¤Î©Î¤zÂZ¨ä¹Lµ{¡A²×¦Ó­­¨î»Ã¯À¤§¤Àªc¡A­°§C°Êª«®ø¤Æ¤é³Àç¾i¤À¤§®Ä²v¡C

ªí¤G §t¥Í¤j¨§¤é³¹ï¥J¯b¸V¯ØŦ¤§¼vÅT

¡@

¯Ø Ŧ ¤j ¤p

¯ØŦ»Ã¯À¤Àªc

¹«¤Î¤j¥Õ¹«

¥Ð¹«¤Î¤ÑªÇ¹«

Âû°¦¤ÎÂúÃZ

óγ½

¥J½Þ

Ã}¤û

µU

¤HÃþ*

¡Ï¡Ï

¡Ï¡Ï

¡Ï¡Ï

n.c.

n.c.

n.c.

n.c.

¡H

¡Ï

¡Ï

¡Ï

¡H¡H

¡Ïor¡Ð

¡H¡H

¡H¡H

¡Ï

¡Ï¡Ï¡A¯ØŦ¤j¤p¼W¥[¡Fn.c.¡AµLÅܤơF¡H¡A¤£½T©w¡F

¡Ï¡A¯ØŦ»Ã¯À¤Àªc¼W¥[¡F¡Ð¡A¤Àªc´î¤Ö¡F??¡A¤£½T©w¡F*¡A¤j¨§¯Ø³J¥ÕúA§í¨î¦]¤l¡C

ªí¤T«Y¤j¨§¤é³¹ï¯ØŦ¥H¥~¤§¨ä¥L²Õ´ªº¼vÅT¡CÁý¤©¥Í¤j¨§©Î¤j¨§¨Å²M³J¥Õ(S- oybean whey proteins)¤Þ°_¹«¤p¸z°®ª«­«ÅãµÛ¦a¼W¥[¡C±À¨s¨ä¦]¡A¤Dlectin¤Î¨ä¥L§ÜÀç¾i¦]¤l©Ò»¤µo¤§²Ó­M¼W¥Í»P¤p¸zÖß½¤¶q¼W¥[¤§¬G(Grant et al., 1989)¡F©óÂû°¦¡BÂúÃZÁý¤©¥Í¤j¨§¤é³¤ÎÃ}¤ûµ¹¹}¸g¥[¼ö³B²z¤§¤j¨§²Ë¥ç¨ã¬Û¦P±¡§Î¡C¥Í¤j¨§¹ï¬Û¹ï¨x­«¤§¼vÅT¡A¦b¹«¤è­±µLÅãµÛ§ïÅÜ¡A¦ý¹ïÂúÃZ¡B½Þ°¦«h¦³ÅãµÛ¼W­«¤§²{¶H¡FTemler et al. (1983)«ü¥X¡A¾¨ºÞ¦b¬Û¹ï¨x­«¤è­±µLÅãµÛ¼vÅT¡A¦ý¥Í¤j¨§¤§Áý¹}¡A¤w¨Ï¹«¤§¨xŦ¥NÁ¡B¨xŦ»Ã¯À¬¡©Ê»P¨xŦ¤¤polysome¤§»E¦X§@¥Î¨ü¨ì§ïÅÜ¡C¥Íªø½Þ¡BªÎ¨|½Þ(Castell¡@and Cliplef, 1988)¡B¹«(Grantet al., 1987)¦]Áý¤©°ª¶q¤j¨§©Î¤j¨§¨Å²M³J¥Õ¦Ó­°§C¦Ù¦×­«¶q»P¦Ù¦×²Ê³J¥Õ½è¡FÂû°¦Áý¹}¥Í¤j¨§¡A«h­°§C¦Ù¼ß³J¥Õ§t¶q¡A¼W¥[°©Àf¦Ù¤¤«D³J¥Õ´á¶q(Santidrian et al., 1980)¡C

ªí¤T Áý¹}¥|ºØ³J¥Õ½è¤é³10¤Ñ«á¡A¹«¦U³¡²Õ´¡B¾¹©x¤§°®ª«­«(§J¡þ100§J)°®Åé­«

¡@

¥Õ³J¥Õ¹ï·Ó²Õ

¸g¥[¼ö³B²z¤§¤j ¨§ ²Ë ²Õ

¥Í ¤j ¨§ ²Õ

¤j ¨§ ¨Å ²M

³J ¥Õ ²Õ

¤p ¸z

¯Ø Ŧ

¨x Ŧ

¤ñ¥Ø³½¦Ù**

ðù ¦Ù**

µÌ ¸z ¦Ù**

2.00±0.03

0.46±0.04

3.41±0.03

0.08±0.01

0.15±0.01

0.79±0.02

1.98±0.05

0.37±0.02*

3.41±0.03

N.D.

N.D.

N.D.

2.20±0.02*

0.63±0.01*

3.48±0.04

0.08±0.01

0.14±0.01

0.76±0.02

2.50±0.10*

0.68±0.05*

3.56±0.08

0.08±0.01

0.12±0.01

0.70±0.01*

* »P¹ï·Ó²Õ·¥ÅãµÛ®t²§(P¡Õ0.01)¡C **¨ú¦Û¨â«á»Lªº¦Ù¦×Á`­«¡C

***¥i·»©ópH4.8¤§³J¥Õ½è¡C N.D.¥¼´ú±o¡C

¥Í¤j¨§¤¤©Ò§tªº§ÜÀç¾i¦]¤l¨s³º¦³¨º¨Ç©O¡HGrant(1989)«ü¥X¡A¸g¥h¯×¤§¤j¨§²ËµÑ¨ú²G¤¤§t¦³¤T¤j³¡¥÷¡G(1)pH8®É¤§¤£·»©Ê´Ý°ò¡A­Y¥H²æ¯×¤j¨§²Ë¬°100®É¡A«h¬ù¦û31.5¢H¡F(2)»Ä¨I¾ý©Ê³J¥Õ½è¡A·»©ópH8¡A¦Ó¦bpH4.8¨I¾ý¡A¬ù¦û32.2¢H¡F¶i¤@¨B¥i¤ÀÂ÷¥X11S²y³J¥Õ(glycinin)¤Î7S²y³J¥Õ(conglycinin)¡F(3)¨Å²M³¡¥÷¡A·»©óp- H4.8¡A¬ù¦û5.8¢H¡A§t¦³trypsin inhibitors(Kunitz inhibitor¡A¤À¤l¶q21,000¤ÎBowm-an-Birk inhibitor¡A¤À¤l¶q¬°8,000)»Plectin¡C¦¹¥~¥t§t¦³¨Å²Mº¯ªRª«¡A¬ù¦û30¢H¡A¥iÂǥѳzªR¹Lµ{¥[¥H¥h°£¡Cglycinin¡Bconglycinin¨Ã¤£·|³y¦¨¯ØŦªº¸~¤j¡A¦ý·|»P¸z¹D¤¤peyer¡¦s patches¤§M-callsµ²¦X¤Þµo§ÜÅé¤ÏÀ³(Grant,1989)¡FSissons et al.(1982)«ü¥X¡A¤W­z¨âºØ§ÜÀç¾i¦]¤l¡A¥i§Q¥Î¼ö²G©Ê¤A¾JµÑ¨ú¤èªk(hot aqueous ethanol extra-ction)¥[¥H¥h°£¡F¦ý²G©Ê¥[¼ö³B²z(aqueous heat treatment)¨ÃµLªk¹F¨ì¦¹¤@¥Øªº¡C

ªí¥| ¥h ¯× ¤j ¨§ ²Ë ¤§ ¤@ ¯ë ²Õ ¦¨

¡@

¶q(§J)

´á ¶q(§J)

²æ¯×¤j¨§²Ë

pH8¤§¤£·»©Ê´Ý°ò

11S²y³J¥Õ(glycinin)*

7S²y³J¥Õ(conglycinin)*

¨Å²M³J¥Õ

¨Å²Mº¯ªRª«

100.0

31.5

11.2

21.0

5.8

30.0

7.9

1.8

1.8

3.0

0.8

0.4

*»Ä¨I¾ý©Ê³J¥Õ½è¡C Grant¡A1989

¡@

¤j¨§¨Å²M³J¥Õ¦¨¥÷(trypsin inhibitors¡Blectin)¡A¨ã­°§C¯×ªÕ§l¦¬¡B¼W¥[ÁxÅnªÅ­«¡A³y¦¨¤p¸z¸~¤j¤Î¦Ù¦×·l¥¢¤§­t­±¼vÅT(Grant, 1987)¡F¨Å²Mº¯ªRª««h§t¦³§C¤À¤l¶qªºoligopcptide©Îglycopeptide¡A·|­°§C¥Íªø¡A³y¦¨¯ØŦ¸~¤j¡A¨Ã´î¤Ö¥Òª¬¸¢¹ï¸K¤§§l¦¬(Konijn et al., 1972¡Cµ¥¶qÁý¤©§t10¢H¤j¨§¨Å²M©Î¥h¥~·½¾®¶°¯À¤§¤j¨§¨Å²M³J¥Õ¡A§í©Î§t0.7¢H lectin©Î2.8¢H trypsin inhibitors(§tKunitz inhibitor¤ÎBowman-Birk in-hibitor)¡F¹ï·Ó²Õ«h¥Hlactalbumin¥[¤J§tlectin¤Îtrypsin inhibitors¤§¤é³¤¤¡C©ó16¤Ñ¤§¸ÕÅç´Áµ²ªGÅã¥Ü¡A¹ï·Ó²Õ¨ã³Ì¨Î¼W­«¡A¨ä¥L¨Ì§Ç¬°¥h¥~·½¾®¶°¯À¤§¤j¨§¨Å²M³J¥Õ²Õ¡Btrypsin inhibitors²Õ¡Blectin²Õ¡A§t¤j¨§¨Å²M³J¥Õ²Õ«h¥Íªø³Ì®t¡CKakade et al. (1973)¸ÕÅç«ü¥X¡Atrypsin inhibitors·|­°§C¥Íªø³t²v¬ù40¢H¡FFujita et al. (1979)¶i¤@¨B«ü¥X¦¹ºØ¸~¤jªº¹Lµ{³Ìªì«Y¯ØŦ²Ó­M¤§¼W¤j¡A¦Ó«á¬°¸¢­M¤Î±ÆªnºÞ²Ó­M¤§¼W¤j»P¼W¥Í©Ò­P¡C

¤j¨§¤¤©Ò§t¤§¥~·½¾®¶°¯À(lectin)¬°ÁÞ³J¥Õ¤§½Æ¦Xª«¡A¤À¤l¶q12,000¡F·íÁý¤©§t¥~·½¾®¶°¯À¤§¤é³«á¡A¥~·½¾®¶°¯À·|µ²¦X©ó¤p¸z°ò³¡¤§¤W¥Ö²Ó­Mªí­±¡A¦Ó¬°¸z²Ó­M©Ò§l¤J¨ì¹FªOª¬¼h¡A¦A¶i¤JÅé´`Àô¤¤¡F¨Ã³y¦¨µ³¤òÅܲʡBÅܵu¡A§õ°ö©ø¤ó¸¢ºÛ¥[²`¡A¤Þ°_Àç¾i§l¦¬¤W¤§¤£¨}¼vÅT¡C

¹«¡B¥Ð¹«¡Bª¯¡B½Þ¡BÃ}¤û¡BÂû°¦¤Î¤HÃþ¤§¯ØŦ»Ã¯À¤Àªc¬°¤@­t°jõX¾÷¨î(negative feedback mechanism)¡F¯ØŦ»Ã¯À¤§¤Àªc³t²v»P¤p¸z«eºÝ¤§¯ØÁx¤Àªc(pancreaticobiliary secretions)¿@«×§e¬Û¤ÎÃö«Y(Grant et al., 1989)¡CFushiki and Iwai (1989)«ü¥X¡A¹«¤§­t°jõX½Õ¸`¾÷¨î¡A¥D­nÂǥѪŸz¤ºªc²Ó­M¤Àªc¤§ÁYÁxÅnúV(cholecystokinin, CCK)©Ò§@¥Î¡FÁYÁxÅnúV¤§ÄÀ©ñ«h¨üªÅ¸z¤¤°ª¿@«×¤§¯Ø³J¥ÕúA¡þ¯Ø¾®¨Å³J¥ÕúA©Ò§í¨î¡CGrant (1989)¶i¤@¨B¸ÑÄÀ¡A¤é³¤¤©Ò§t¤§trypsin inhibitors«YÂÇ­°§C¤p¸z¤¤¤§´åÂ÷ºA¯Ø³J¥ÕúA¤Î¯Ø¾®¨Å³J¥ÕúA¡A¤zÂZ¥¿±`¤§°jõX±±¨î¾÷¨î¡A¦]¦Ó¼W¥[ÁYÁxÅnúVÄÀ©ñúVÐ`(CCK releasing peptide)µ²¦X©óªÅ¸z¤ºªc²Ó­M¤§¿@«×¡AÄÀ©ñ¥X°ª¶q¤§´`Àô©ÊÁYÁxÅnúV¡A²×¦Ó³y¦¨¯ØŦ»Ã¯À¤§¹L«×¤Àªc¡A¤Þ°_¯ØŦ¤§¼W¤j»P¼W¥Í(Fushiki and Iwai, 1989)¡C¦¹ºØ°jõX©Ê½Õ¸`¤§­º­n¶Ç¾Éª«½è¦]°Êª«ºØ§O¤§¤£¦P¦Ó¦³¨ä®t²§¡ACorring et al.(1986)¡BSh- iratori et al. (1989)§Y«ü¥X¡AÁöµMÁYÁxÅnúV¹ï¹«¦Ó¨¥¬°­º­n¤§¶Ç¾Éª«½è¡A¦ý¦b½Þ¡B¤ü¶È¦û¦¸­n¤§¦a¦ì¡F¹ê»Ú¤W¤§­º­n¶Ç¾Éª«½è¬°¤p¸z¤ºªc¯À(Secretin)¡C

¤T¡B¤j¨§¹ï¹}¾i®ÄªG¤§¼vÅT

Pontif et al.(1987)¨Ï¥Î136°¦¤T«~ºØ½ü°jÂø¥æ½Þ(Hammpshires¡BYorkshires¡BDur- ocs)¡A¥­§¡Åé­«©ó¸ÕÅç¤@»P¸ÕÅç¤G¤À§O¬°62¤Î57¤½¤ç¤§3.5¤ëÄ֪Ψ|½Þ¡A¥H¶i¦æ¥Í¤j¨§¤§¹}¾i®ÄªG¬ã¨s¡C¥|¤é³³B²z²Õ¤À§O¥H¥Í¤j¨§¨ú¥N¤j¨§²Ë©Ò¦û²Ê³J¥Õ½è0¢H¡B33¢H¡B67¢H¡B100¢H¤§¤ñ¨Ò¡Cµ²ªGÅã¥Ü¼W­«»P¹}®ÆÂà´«²vÀH¥Í¤j¨§²K¥[¤ñ²v¤§¤W¤É¦Ó§e½u©Ê¤U­°(P¡Õ0.01¡Aªí¤»)¡F¤é¼W­«¥çÀH¥Í¤j¨§²K¥[¶q´£°ª¦Ó­°§C¡C¦Ó¦b±OÅé­«¤è­±¡A«h§e½u©Ê¤U­°¡A«Y¨üÅé¼W­«­°§C©Ò¼vÅT(ªí¤C¡BPonif et al., 1987)¡CLEA(²Ä10¦Ø°©¤§¸y²´­±¿n)»P¸K»ù¥çÀH¥Í¤j¨§¤§²K¥[¤ñ²v´£°ª¦Ó§e½u©Ê¼vÅT(P¡Õ0.01¡Aªí¤C)¡C§@ªÌ«ü¥X¥Í¤j¨§²K¥[¶q´£°ª­P¸y²´­±¿n´î¤Ö¡A¥i¯à»P¥Í¤j¨§¤¤©Ò§ttrypsin in-hibitors¡A¨Ï³J¥Õ½è¤§¥i§Q¥Î©Ê­°§C¤Î¡þ©Î¥Í¤j¨§¤¤¤§§¿¯ÀúA¬¡¼â«×¦³Ãö¡A­P¯Ê¥F¤@ºØ©Î¦hºØÓi°ò»Ä¡A¦X¦¨¦Ù¦×¤§¯à¤O¦]¦ÓÅÜ®t¡C§@ªÌµ²½×«ü¥X¡A¥H¥Í¤j¨§²K¥[©óªÎ¨|½Þ¤é³¤¤Áý¹}50¤Ñ¡A·|­°§C¼W­«¤Î¹}®ÆÂà´«²v¡A¨Ã¼vÅT¸y²´­±¿n¡B­°§C±OÅé«~½è¡F¬G¤£±ÀÂË©ó°l¨D³Ì¤j¼W­«¡B³Ì¨Î¹}®ÆÂà´«²v»P±OÅé«~½è¤§¹}¾i¥Ø¼Ð¤W¡C³]­Y°ò©ó¸gÀÙ¦Ò¶q¡A«h¥Í¤j¨§²K¥[©óªÎ¨|´Á½Þ°¦¤é³¤¤¥ç¤£À³¶W¹L13¢H¡C

ªí¤­ ¹ê Åç ¤é ³ ²Õ ¦¨ (1)

­ì ®Æ ²Õ ¦¨

¥Í ¤j ¨§ ¦Ê ¤À ¤ñ

0

33

67

100

¥É ¦Ì

¤j ¨§ ²Ë

¥Í ¤j ¨§

ÁC »Ä ²B ¶t

¨d Ä÷ ´ß ¯»

Äqª«½è¹w©Õª«

ºû¥Í¯À¹w©Õª«

¯Ø³J¥ÕúA§í¨î¦]¤l¡A²@§J¡þ§J¤é³

¢w¢w¢w¢w¢w¢w¢w¢w¢H¢w¢w¢w¢w¢w¢w¢w¢w

81.75

15.84

1.08

0.78

0.30

0.25

80.51

10.71

6.37

1.08

0.78

0.30

0.25

1.18

79.22

5.44

12.93

1.08

0.78

0.30

0.25

2.40

77.86

19.73

1.08

0.78

0.30

0.25

3.67

µù¡G(1)µ¥³J¥Õ½è¡Bµ¥¥NÁ¯à¤é³(C.P.14¢H¡AM.E.3200¥a¥d¡þ¤½¤ç)¡C

¡@

ªí¤» ªÎ¨|½ÞÁý¹}¥Í¤j¨§¹ï¼W­«»P¹}®ÆÂà´«²v¤§¼vÅT(1)

¤é ³ ³B ²z ²Õ

¼W ­« ¡A ¤½ ¤ç

¹}®ÆÂà´«²v(¼W­«¡þ¹}®Æ)

°ò¦¤é³(B¡A¢H)

B¡Ï 33¢H¥Í¤j¨§

B¡Ï 66¢H¥Í¤j¨§

B¡Ï100¢H¥Í¤j¨§

Pooled SE

0.825

0.754

0.763

0.696

0.017

0.276

0.278

0.268

0.253

0.004

µù¡G(1)¨â¸ÕÅ祭§¡¸ê®Æ¡C

¡@

ªí¤C ªÎ ¨| ½Þ Áý ¹} ¥Í ¤j ¨§ ¹ï ±O Åé ©Ê ª¬ ¤§ ¼v ÅT (1)

¤é ³ ³B ²z ²Õ

±OÅé­«¡A¤½¤ç

±O®_²v¡A¢H

¸y²´­±¿n¡Acm2

­I¯×«p¡Amm

¸K »ù

°ò¦¤é³(B¡A¢H)

B¡Ï 33¢H¥Í¤j¨§

B¡Ï 66¢H¥Í¤j¨§

B¡Ï100¢H¥Í¤j¨§

Pooled SE

86.1

82.6

82.9

81.2

1.05

80.7

80.2

80.7

80.5

0.54

30.0

28.5

27.7

26.0

0.61

33.9

32.7

34.1

34.7

0.96

61.6

63.4

67.1

68.9

0.69

µù¡G(1)¨â¸ÕÅ祭§¡¸ê®Æ¡C

¡@

Cook et al. (1988)¤À§O©ó¸ÕÅç¤@¡B¸ÕÅç¤G¨Ï¥Î36°¦¤Î48°¦¡A¥­§¡Åé­«7.0¤Î67¤½¤ç¤§Âø¥æìI¤½½Þ(Landrace¡ÑDuroc¡ÑYorkshire)¡F¸ÕÅç¤T«h¨Ï¥Î18ÀY¥­§¡Åé­«12.4¤½¤ç¤§Âø¥æìI¤½½Þ¡A¥H¤ñ¸ûKunitz trypsin inhibitor¹ï¥Íªø´Á¶¡»PªÎ¨|´Á½Þ°¦¥Íªø©Ê¯à¡B³J¥Õ½è¤Î¯à¶q»W¿n¤§¼vÅT¡C¤é³²Õ¦¨¦pªí¤K¡Bªí¤E©Ò¥Ü¡C

ªí¤K ¸Õ Åç ¤@ ¡B ¤G ¤§ ¤é ³ ²Õ ¦¨

¶µ ¥Ø

¸Õ Åç ¤@

¸Õ Åç ¤G

¤j¨§²Ë²Õ(1)

LT©ÎHT²Õ(2)

¤j¨§²Ë²Õ

LT©ÎHT²Õ

¥É ¦Ì

¤j ¨§ ²Ë

¥Í ¤j ¨§

¥É ¦Ì ªo

ÁC »Ä ²B ¶t

¥Û ¦Ç ¥Û ¯»

Äqª«½è¹w©Õª«

ºû¥Í¯À¹w©Õª«

§Ü ¥Í ¯À

Á` ­p

64.30

26.00

7.00

1.25

0.75

0.35

0.10

0.25d

100.00

65.30

32.00

1.25

0.75

0.35

0.10

0.25

100.00

82.95

14.00

¡@

1.25

1.25

0.35

0.10

0.10e

100.00

78.91

18.00

1.25

1.25

0.35

0.10

0.10

100.00

¡@

¢w¢w¢w¢w¢w¢w¢w¢w¢w ­pºâ­È ¢w¢w¢w¢w¢w¢w¢w¢w¢w

²Ê³J¥Õ½è¡A¢H

Â÷ Ói »Ä¡A¢H

Á`¯à¡A¦Ê¸U¥d¡þ¤½¤ç

Á`¯à¡A¦Ê¸U¥d¡þ¢HÂ÷Ói»Ä

18.30

0.93

4.13

4.44

18.00

0.93

4.13

4.50

14.00

0.62

3.80

6.13

13.90

0.65

3.99

6.14

µù¡G(1)¤j¨§²Ë²Õ¡G¸g¥[¼ö¡A·»¾¯µÑ¨ú¤§¤j¨§²Ë¡C

(2)LT©ÎHT²Õ¡G¨C¤½§J¥Í¤j¨§°®ª«¶q¤¤¡A§t¦³0.5²@§J(LT²Õ)¡A5²@§J(HT²Õ)¤§Kunitz trypsin inhibitor¡C

ªí¤E ¸Õ Åç ¤T ¤§ ¤é ³ ²Õ ¦¨ (1)

¶µ ¥Ø

¤j ¨§ ²Ë ²Õ

LT©ÎHT²Õ

¤j ¨§ ²Ë

¥Í ¤j ¨§

¥É¦Ì¾ý¯»

¥É ¦Ì ªo

ÅÖ ºû ¯À

ÁC»Ä²B¶t

¥Û¦Ç¥Û¯»

Äqª«½è¹w©Õª«

ºû¥Í¯À¹w©Õª«

DL¡Ð¥Ò²¸Ói»Ä

§Ü ¥Í ¯À

Ethoxyguin (250ppm)

Á` ­p

­p ºâ ­È

²Ê³J¥Õ½è¡A¢H

Â÷ Ói »Ä¡A¢H

Á`¯à¡A¦Ê¸U¥d¡þ¤½¤ç

Á`¯à¡A¦Ê¸U¥d¡þ¢H¡AÂ÷Ói»Ä

34.00

53.55

6.00

2.00

2.25

0.75

0.35

0.50

0.35

0.25

¡Ï

100.00

16.20

1.02

3.90

3.82

48.00

45.55

2.00

2.25

0.75

0.35

0.50

0.35

0.25

¡Ï

100.00

18.25

1.06

4.12

3.89

µù¡G¦pªí¤Kµù¸}¡C Cook et al., 1988

¥­§¡¤é³­«»P¹}®ÆÂà´«²v(¼W­«¡þ¹}®Æ)©ó¸ÕÅç¤@(¥Íªø´Á)¤¤¬Ò¥H§t°ª¶q¯Ø³J¥ÕúA§í¨î¦]¤l²Õ³Ì®t¡A¤À§O­°§C52¢H¤Î53¢H¡A¦Ó§t§C¶q¯Ø³J¥ÕúA§í¨î¦]¤l²Õ¥ç·¥ÅãµÛ¦a­°§C(P¡Õ0.01)¤é¼W­«»P¹}®ÆÂà´«²v(ªí¤Q)¡F¤j¨§²Ë°ò¦¤é³²Õ«h¦³³Ì¨Î¤§¥Íªø©Ê¯à(ªí¤Q)¡C

ªí¤Q Áý ¹} ¤j ¨§ ²Ë »P ¥Í ¤j ¨§ ¤§ ¥Í ªø ´Á ½Þ ½Þ ¥Í ªø ©Ê ¯à

¶µ ¥Ø

¤j¨§²Ë²Õ

§t§C¶q¯Ø³J¥Õ§í¨î¦]¤l²Õ

§t°ª¶q¯Ø³J¥Õ§í¨î¦]¤l²Õ

SE

ªì Åé ­«¡A¤½¤ç

¤é ¼W ­«¡A¤½¤ç

¤é±Ä­¹¶q¡A¤½¤ç

¹}®ÆÂà´«²v(¼W­«¡þ¹}®Æ)

6.8

0.436c

0.864

0.505c

7.2

0.286d

0.745

0.386d

6.8

0.211c

0.895

0.236c

0.057

0.172

0.051

c¡Bd¡Beªí·¥ÅãµÛ®t²§(P¡Õ0.01)¡C

¡@

©ó¸ÕÅç¤G(ªÎ¨|´Á)¤è­±¡A¤é¼W­«¤´¥H§t°ª¶q¯Ø³J¥ÕúA§í¨î¦]¤lªÌ³Ì®t(P¡Õ0.05)¡A¦Ó¦b¹}®ÆÂà´«²v¤W«h¥¼¹FÅãµÛ®t²§¤ô·Ç¡FÅã¥Ü¯Ø³J¥ÕúA§í¨î¦]¤l¤§¼vÅT»P¤éÄÖ¦³Ãö¡C

ªí11 Áý ¹} ¤j ¨§ ²Ë »P ¥Í ¤j ¨§ ¤§ ªÎ ¨| ½Þ ¥Í ªø ©Ê ¯à

¶µ ¥Ø

¤j¨§²Ë²Õ

§t§C¶q¯Ø³J¥Õ§í¨î¦]¤l²Õ

§t°ª¶q¯Ø³J¥Õ§í¨î¦]¤l²Õ

SE

ªì Åé ­«¡A¤½¤ç

¥½ Åé ­«¡A¤½¤ç

¤é ¼W ­«¡A¤½¤ç

¤é±Ä­¹¶q¡A¤½¤ç

¹}®ÆÂà´«²v(¼W­«¡þ¹}®Æ)

68

106

0.95c

3.27

0.291

67

103

0.87d

2.97

0.293

67

101

0.83e

3.07

0.270

¡@

0.01

0.45

0.02

c¡Bd¡BeªíÅãµÛ®t²§(P¡Õ0.05)¡C

´á¤§®ø¤Æ²v»P»W¿n²v¡A¤T³B²z²Õ¶¡¬Ò§eÅãµÛ®t²§(P¡Õ0.05)¡A©ó´á¤§®ø¤Æ²v¤W§ó¹F·¥ÅãµÛ¤ô·Ç(P¡Õ0.01)¡F¯à¶q¤§®ø¤Æ²v»P¥i¥NÁ²v©ó¹ï·Ó²Õ»P§t¯Ø³J¥ÕúA§í¨î¦]¤l¤§¨â³B²z²Õ¶¡¬Ò§eÅãµÛ®t²§(P¡Õ0.05¡Aªí¤Q¤G)¡C¤j¨§²Ë¸g¾A·í¥[¼ö¹Lµ{¡A¥i¦³®Ä¯}Ãa¯Ø³J¥ÕúA§í¨î¦]¤l(Liener and Kakade,1969)»P¤j¨§¬õ¦å²y¾®¶°¯À¡Ð¥~·½¾®¶°¯À¡F¥Ñµ²ªG¥iª¾¡A§t§C¶q¯Ø³JúA§í¨î¦]¤l(0.5²@§J¡þ§J°®ª«½è)¹ï½Þ°¦§Y¨ã§í¨î¥Íªø¡A­°§C´á®ø¤Æ²v¡A»W¿n²v»P¯à¶q®ø¤Æ²v¤§­t­±¼vÅT¡CEndres¤]«ü¥X¡AKunitz inhibitor·|§í¨î³Ì¤j¤§³J¥Õ½è§Q¥Î¡A¦ÓBowman-Birk inhibtor¤Î¨ä¥L§í¨î¦]¤l±N¶i¤@¨B§í¨î³J¥Õ½è¤§§Q¥Î¡C¥ÑCook et al. (1988)¤§¸ÕÅçÃÒ¹ê¥Í¤j¨§¤¤©Ò§t¤§§ÜÀç¾i¦]¤l¡A½T¹ê¤£§Q©ó®a¯b¤§¥Íªø©Ê¯à¡A¤×¥H¥Íªø¶¥¬q¬°µM¡C

¡@

ªí12 ¥­ ¿Å ¸Õ Åç µ² ªG ( ¸Õ Åç ¤T )

¶µ ¥Ø

¤j¨§²Ë²Õ

§t§C¶q¯Ø³J¥Õ§í¨î¦]¤l²Õ

§t°ª¶q¯Ø³J¥Õ§í¨î¦]¤l²Õ

SE

´á

Á`Äá­¹¶q¡A§J

¥i®ø¤Æ³¡¥÷¡A¢H

»W¿n²v¡A¢H

¯à¶q

Á`Äá­¹¶q¡A¦Ê¸U¥d

¥i®ø¤Æ³¡¥÷¡A¢H

¥i®ø¤Æ³¡¥÷¡A¢H

129

91.4c

65.9f

15.9

93.9c

91.9c

139

83.9d

59.5g

16.6

87.6d

84.6d

136

79.1e

50.9h

16.5

85.9d

83.8d

¡@

1.83

2.76

¡@

1.56

2.54

c¡Bd¡BeªíÅãµÛ®t²§(P¡Õ0.05)¡C

f¡Bg¡Bhªí·¥ÅãµÛ®t²§(p¡Õ0.01)¡C

¥|¡Bµ² ½×

1.¥Í¤j¨§©Î¥[¼ö¤£·í¤§¤j¨§²Ë§t¦³§ÜÀç¾i¦]¤l(anti-nutritional factors)¤§¦s¦b¡A¤wª¾¬°glycinin¡Bconglycinin¡Blectin¡BKunitz inhibitor¤ÎBowman-Birk inhibitor¡C·íÁý¤©®a¯b¸V(¯S§O¬O¥Íªø¶¥¬q¤§¥J¯b)¡A·|­°§C¥Íªø©Ê¯à¡A­°§C´á¤§®ø¤Æ²v¤Î»W¿n²v¡F¨Ã¨Ï¤é³¤¤´á¡BºÒ¤ô¤Æ¦Xª«¡B¯×½è¤§®ø¤Æ»P§l¦¬¨ü¨ä¼vÅT¡C¹ïÂû¡BÂúÃZ¦Ó¨¥¡A¥ç·|³y¦¨¯ØŦ¸~¤j¡B¯ØŦ»Ã¯À¹L«×¤Àªc¡A¦]¦ÓµLªk¥R¤À¤À¸Ñ¤é³Àç¾i¤À¡A¾É­P®ø¤Æ¤£¨}¡B¥ÍªøÅÜ®t¡C¾A·íªº¥[¼ö³B²z¤j¨§²Ë¡A¥i¥h°£©Ò§t¤j³¡¥÷¤§§ÜÀç¾i¦]¤l¡F±©±ý¹F§¹¥þ¤§®ÄªG¡A«h¥H¼ö²G©Ê¤A¾JµÑ¨úªk(hot aque ous-ethanol extraction)¬°³Ì¨Î¡C

2.®Ú¾Ú¬ã¨s«ü¥X¡A¥Í¤j¨§²K¥[©óªÎ¨|½Þ°¦¤é³¤¤¡AÅãµÛ­°§C¥Íªø©Ê¯à»P±OÅé«~½è¡F±©­Y°ò©ó¸gÀÙ¦Ò¶q¡A«h²K¥[¶q¤£¥i¶W¹L13¢H¡C¦¹¥~Cook et al. (1988)¥çÃÒ¹ê¡A§Y¨Ï«D±`§C¶q(0.5²@§J¡þ§J°®ª«½è)¤§Kunitz trypsin inhibitor¡A¥i¹ï¥Íªø½Þ¤ÎªÎ¨|½Þ³y¦¨ÅãµÛ¤§¥Íªø©Ê¯à¡A´á¤Î¯à¶q®ø¤Æ²v»P»W¿n²v¤§­°§C¡A¤×¥H¥Íªø´Á¬°µM¡C¬O¥H¹}®Æ­ì®Æ¤§²Õ¦¨¯S©Ê¡A¹}®Æ­ì®Æ©¼¦¹¶¡¤§§@¥ÎÃö«Y¡A¥H¤Î­ì®Æ¤¤©Ò§t¬rª«¦]¤l©Î§ÜÀç¾i¦]¤l¡A¬Ò¶·©ó¤é³½Õ°t®É¼f·V³B²z¡C

¡@

¹}®ÆÀç¾iÂø»x(3~16)

92¦~¡D²Ä¤G´Á¢w¤ý³Ó¼w

Copyright © 1998 ­Z¸s®n¯bªªºô. ¥»ºô¯¸¹Ï¤å«YÄÝ­Z¸s®n¦³­­¤½¥q¡A¤º¤å¤§ª©Åv¬°¸ÓÂø»xªÀ©Ò
¦³¡A«D¸g¥»¤½¥q¤Î¸ÓÂø»xªÀ¥¿¦¡®Ñ­±¦P·N¡A¤£±o±N¥þ³¡©Î³¡¤À¤º®e¡A
Âà¸ü©ó¥ô¦ó§Î¦¡´CÅé   ¡° ³Ì¨Î¸ÑªR«× 800x600
Copyright © 1998 MiobufferCo., Ltd.  All rights reserved.
Unauthorized copying and reproduction is prohibited. All trademarks property of their respective holders.